Effect of interleukin 12 on in vitro HIV type 1 replication depends on clinical stage

AIDS Research and Human Retroviruses

Volumn 12, Issue 8, 1996, Pages 659-668

  Perales, Miguel Angel ^a   Skolnik, Paul R ^b   Lieberman, Judy ^a,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CENTER FOR BLOOD RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN P24; CD4 ANTIGEN; CD8 ANTIGEN; CYTOKINE; DIDANOSINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 4; RECOMBINANT INTERLEUKIN 12; RECOMBINANT INTERLEUKIN 2; ZALCITABINE; ZIDOVUDINE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOMODULATION; IMMUNOTHERAPY; LYMPHOCYTE CULTURE; MALE; PRIORITY JOURNAL; T LYMPHOCYTE; VIRUS EXPRESSION; VIRUS INHIBITION; VIRUS REPLICATION;

EID: 0030005237     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.1996.12.659     Document Type: Article

References (40)

1. Kobayashi M, Fitz L, Ryan M, Hewick RM, Clark SC, Chan S, Loudon R, Sherman F, Perussia B, and Trinchieri G: Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biological effects on human lymphocytes. J Exp Med 1989;170:827-845.
2. Stern AS, Podlaski FJ, Hulmes JD, Pan Y-CE, Quinn PM, Wolitzky AG, Familletti PC, Stremlo DL, Truitt T, Chizzonite R, and Gately MK: Purification to homogeneity and partial characterization of cytotoxic lymphocyte maturation factor from human B-lymphoblastoid cells. Proc Natl Acad Sci USA 1990;87:6808-6812.
3. Gately M, Desai B, Wolitzky A, Quinn P, Dvvyer C, Podlaski F, Familletti P, Sinigaglia F, Chizzonite R, Gubler U, and Stern A: Regulation of human lymphocyte proliferation by a heterodimeric cytokine, IL12 (cytotoxic lymphocyte maturation factor). J Immunol 1991;147:874-882.
4. Wolf S, Temple P, Kobayashi M, Young D, Dicig M, Lowe L, Dzialo R, Fitz L, Ferenz C, Hewick R, Kelleher K, Hermann S, Clark S, Azzoni L, Chan S, Trinchieri G, and Perussia B: Cloning of cDNA for natural cell stimulatory factor, a heterodimeric cytokine with multiple biologic effects on T and natural killer cells. J Immunol 1991;146:3074-3081.
5. Gubler U, Chua A, Schoenhaut D, Dwyer C, McComas W, Motyka R, Nababavi N, Wolitzky A, Familletti P, Stremlo D, Truitt T, Chizzonite R, and Gately M: Co-expression of two distinct genes is required to generate secreted bioactive cytotoxic lymphocyte maturation factor. J Immunol 1991;88:4143-1147.
6. Chan SH, Perussia B, Gupta JW, Kobayashi M, Pospisil M, Young HA, Wolf SF, Young D, Clark SC, and Trinchieri G: Induction of interferon γ production by natural killer cell stimulatory factor: Characterization of the responder cells and synergy with other inducers. J Exp Med 1991;173:869-879.
7. Robertson MJ, Soiffer RJ, Wolf SF, Manley TJ, Donahue C, Young D, Hermann SH, and Ritz J: Response of human natural killer (NK) cells to NK cell stimulatory factor (NKSF). Cytolytic activity and proliferation of NK cells are differentially regulated by NKSF. J Exp Med 1992;175:779-788.
8. Bertagnolli MM, Lin B-Y, Young D, and Hermann SH: IL-12 augments antigen-dependent proliferation of activated T lymphocytes. J Immunol 1992;149:3778-3783.
9. Manetti R, Parronchi P, Giudizi MG, Piccinni M-P, Maggi E, Trinchieri G, and Romagnani S: Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells. J Exp Med 1993;177:1199-1204.
10. + T lymphocytes. J Immunol 1993;151:2444-2452.
11. Manetti R, Gerosa F, Giudizi MG, Biagiotti R, Parronchi P, Piccinni M-P, Sampognaro S, Maggi E, Romagnani S, and Trinchieri G: Interleukin 12 induces stable priming for interferon γ (IFN-γ) production during differentiation of human T helper (Th) cells and transient IFN-γ production in established Th2 cell clones. J Exp Med 1994;179:1273-1283.
12. Heinzel FP, Schoenhaut DS, Rerko RM, Rosser LE, and Gately MK: Recombinant interleukin 12 cures mice infected with Lehhmania major. J Exp Med 1993;177:1505-1509.
13. Sypek JP, Chung CL, Mayor SE, Subramanyam JM, Goldman SJ, Sieburth DS, Wolf SF, and Schaub RG: Resolution of cutaneous leishmaniasis: Interleukin 12 initiates a protective T helper type 1 immune response. J Exp Med 1993;177:1797-1802.
14. Gazzinelli RT, Hieny S, Wynn TA, Wolf S, and Sher A: Interleukin 12 is required for the T-lymphocyte-independent induction of interferon γ by an intracellular parasite and induces resistance in T-cell-deficient hosts. Proc Natl Acad Sci USA 1993;90:6115-6119.
15. Murray HW, Rubin BY, Mazur H, and Roberts RB: Impaired production of lymphokines and immune (gamma) interferon in the acquired immunodeficiency syndrome. N Engl J Med 1984;310: 883-889.
16. Bowen DL, Lane HC, and Fauci AS: Immunopathogenesis of the acquired immunodeficiency syndrome. Ann Intern Med 1985;103: 704-709.
17. Fontana L, Sirianni MC, de Sanctis G, Carbonari M, Ensoli B, and Aiuti F: Deficiency of natural killer activity, but not of natural killer binding, in subjects with lymphadenopalhy syndrome positive for antibodies to HTLV-III. Immunobiology 1986;171:425-435.
18. Miedema F, Petit AJ, Terpstra FG, Schattenkerk JK, De Wolf F, Al BJ, Roos M, Lange JM, Danner SA, and Goudsmit J: Immunological abnormalities in human immunodeficiency virus (HIV)-infected asymptomatic homosexual men. HIV affects the immune system before CD4+ helper cell depletion occurs. J Clin Invest 1988;82:1908-1916.
19. Clerici M, Stocks NI, Zajac RA, Boswell RN, Lucey DR, Via CS, and Shearer GM: Detection of three distinct patterns of T helper cell dysfunction in asymptomatic, human immunodeficiency virus-seropositive subjects. Independence of CD4+ cell numbers and clinical staging. J Clin Invest 1989;84:1892-1899.
20. Chehimi J, Starr SE, Frank I, D'Andrea A, Ma X, MacGregor RR, Sennelier J, and Trinchieri G: Impaired interleukin 12 production in human immunodeficiency virus-infected subjects. J Exp Med 1994;179:1361-1366.
21. Chehimi J, Starr SE, Frank I, Rengajaru M, Jackson SJ, Lianes C, Kobayashi M, Perussia B, Young D, Nickbarg E, Wolf SF, and Trinchieri G: Natural killer (NK) cell stimulatory factor increases the cytotoxic activity of NK cells from both healthy donors and human immunodeficiency virus-infected subjects. J Exp Med 1992;175:789-796.
22. Clerici M, Lucey DR, Berzofsky JA, Pinto LA, Wynn TA, Blatt SP, Dolan MJ, Hendrix CW, Wolf SF, and Shearer GM: Restoration of HIV-specific cell-mediated immune responses by interleukin-12 in vitro. Science 1993;262:1721-1724.
23. Kovacs JA, Baseler M, Dewar RJ, Vogel S, Davey RT, Falloon J, Polis MA, Walker RE, Stevens R, Salzman NP, Metcalf JA, Masur H, and Lane HC: Increases in CD4 T lymphocytes with intermittent courses of interleukin-2 in patients with human immunodeficiency virus infection. N Engl J Med 1995;332:567-575.
24. Vartdal F, Kvalheim G, Lea TE, Bosnes V, Gaudernack G, Ugelstad J, and Allbrechtsen D: Depletion of T lymphocytes from human bone marrow. Use of magnetic monosized polymer microspheres coated with T-lymphocyte-specific monoclonal antibodies. Transplantation 1987;43:366-371.
25. Centers for Disease Control. Classification system for the human T-Iymphotropic virus type III/lymphadenopathy-associated virus infection. MMWR 1986;35:334-339.
26. Centers for Disease Control. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR 1993;41:1-19.
27. Walker CM, Moody DJ, Stites DP, and Levy JA: CD8+ lymphocytes can control HIV infection in vitro by suppressing virus replication. Science 1986;234:1563-1566.
28. H0, clones. Eur J Immunol 1994;24:2271-2278.
29. H0 cells. Science 1994;265:244-248.
30. + T-helper cell clones. In: Mechanisms of T Cell Dysfunction in HIV Infection. Ph.D. thesis, Amsterdam University, Amsterdam, The Netherlands, 1995, pp. 125-135.
31. + cell antiviral factor. Cell Immunol 1994;153:329-343.
32. McLeod GX and Hammer SM: Effects of interleukin (IL)-12 on HIV-1 replication in vitro. First Natl. Conf. Hum. Retroviruses Related Viruses 1993;54:356. [Abstract]
33. H2 stimulatory cytokines IL-12 and IL-4 on human immunodeficiency virus replication. Blood 1995;85:2114-2123.
34. Clouse KA, Weih KA, Daniel S, and Cosentino LM: Interleukin-12 enhances HIV-1 replication during acute infection of activated, but not resting human T lymphocytes. AIDS Res Hum Retroviruses 1994;10:119. [Abstract]
35. Kinter AL, Goletti D, Hardy EC, and Fauci AS: Interleukin (IL)-12 allows isolation of HIV from peripheral blood mononuclear cells (PBMCs) and lymph node cells in the presence of CD8-mediated virus suppressor activity. AIDS Res Hum Retroviruses 1994;10: 118. [Abstract]
36. H2 switch is a critical step in the etiology of HIV infection. Immunol Today 1993;14:107-110.
37. Clerici M, Hakim FT, Venzon DJ, Blatt S, Hendrix CW, Wynn TA, and Shearer GM: Changes in interleukin-2 and interleukin-4 production in asymptomatic, human immunodeficiency virus-seropositive individuals. J Clin Invest 1993;91:759-765.
38. Manetti R, Annunziato F, Biagiotti R, Giudizi MG, Piccinni M-P, Giannarini L, Sampognaro S, Parronchi P, Vinante F, Pizzolo G, Maggi E, and Romagnani S: CD30 expression by CD8+ T cells producing type 2 helper cytokines: Evidence for large numbers of CD8+CD30+ T cell clones in human immunodeficiency virus infection. J Exp Med 1994;180:2407-2411.
39. Paganelli R, Scala E, Ansotegui IJ, Ausiello CM, Halapi E, Fanales-Belasio E, D'Offizi G, Mezzaroma I, Pandolfi F, Fiorilli M, Cassone A, and Aiuti F: CD8+ T lymphocytes provide helper activity for IgE synthesis in human immunodeficiency virus-infected patients with hyper-IgE. J Exp Med 1995;181:423-428.
40. Clerici M and Shearer GM: The Th1-Th2 hypothesis of HIV infection: New insights. Immunol Today 1994;15:575-581.